Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | Potency | 819.9 | nM | 6988589 | ||
NPT1197 | Individual Protein | Huntingtin | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT477 | Individual Protein | DNA dC->dU-editing enzyme APOBEC-3G | Homo sapiens | Potency | 1995.3 | nM | 7731021 | |
NPT2 | Others | Unspecified | Potency | 354.8 | nM | 10.1007/s00044-011-9842-7 | ||
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 44668.4 | nM | 10.1007/s00044-011-9882-z |
NPT2 | Others | Unspecified | IC50 | = | 1300 | nM | Open TG-GATES in vivo data: Hematology | |
NPT5114 | Individual Protein | Beta-galactosidase | Escherichia coli | EC50 | > | 40000 | nM | 8277308 |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | 15921421 | ||
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 31622.8 | nM | 24224794 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 819.9 | nM | 12027740 | |
NPT2 | Others | Unspecified | IC50 | = | 7340 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | = | 6513.1 | nM | 18723353 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 2511.9 | nM | 10.6019/CHEMBL1201861 | |
NPT2 | Others | Unspecified | IC50 | = | 2066 | nM | 20655237 | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 1158.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3162.3 | nM | 12350153 | ||
NPT2 | Others | Unspecified | Potency | 9200 | nM | 17067151 | ||
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 1309.2 | nM | 25237727 |
NPT2 | Others | Unspecified | IC50 | = | 220 | nM | 19344127 | |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 15848.9 | nM | 18212109 |
NPT15 | Cell Line | Jurkat | Homo sapiens | IC50 | = | 990 | nM | 20547812 |
NPT2 | Others | Unspecified | Potency | 651.3 | nM | 19015330 | ||
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 56234.1 | nM | 19332670 | |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 3162.3 | nM | 10.1007/s00044-009-9214-8 |
NPT2 | Others | Unspecified | Potency | 4610.9 | nM | 10.1007/s00044-013-0484-9 | ||
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 8912.5 | nM | 23318903 | |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 7079.5 | nM | 23357308 | |
NPT840 | Individual Protein | Transcriptional activator Myb | Gallus gallus | IC50 | = | 706.32 | nM | DrugMatrix in vivo data: Hematology |
NPT2 | Others | Unspecified | Potency | 2238.7 | nM | 26241103 | ||
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 1000 | nM | 10.6019/CHEMBL1201861 |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 4109.5 | nM | 10.6019/CHEMBL1201861 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 2936.2 | nM | 14575438 | |
NPT2893 | Individual Protein | DNA damage-inducible transcript 3 protein | Mus musculus | IC50 | = | 2480 | nM | 15084135 |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 1258.9 | nM | 17672504 |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 6513.1 | nM | Open TG-GATES in vivo data: Pathology | |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 631 | nM | 24689881 |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 4466.8 | nM | 19650641 | |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 1309.2 | nM | 16872140 |
NPT2 | Others | Unspecified | Potency | 7943.3 | nM | PubChem BioAssay data set | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 2078.7 | nM | 18512900 | |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 1258.9 | nM | 20086162 |
NPT2 | Others | Unspecified | Potency | 1412.5 | nM | 23398362 | ||
NPT2 | Others | Unspecified | ED50 | = | 0.29 | ug/ml | 19006372 | |
NPT2 | Others | Unspecified | IC50 | > | 80000 | nM | 21856049 | |
NPT4120 | Individual Protein | G-protein coupled receptor 55 | Homo sapiens | IC50 | = | 4494.35 | nM | 24095094 |
NPT4358 | Individual Protein | Type-1 angiotensin II receptor | Homo sapiens | IC50 | = | 21974 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 3981.1 | nM | 10.1007/s00044-011-9729-7 |
NPT840 | Individual Protein | Transcriptional activator Myb | Gallus gallus | IC50 | = | 710 | nM | DrugMatrix in vitro pharmacology data |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2818.4 | nM | 16643028 | ||
NPT2892 | Individual Protein | X-box-binding protein 1 | Homo sapiens | IC50 | = | 2200 | nM | 18077425 |
NPT1397 | Cell Line | INS1 | Rattus norvegicus | AC50 | = | 2132 | nM | 18077425 |
NPT1283 | Individual Protein | Paired box protein Pax-8 | Homo sapiens | AC50 | = | 742 | nM | 22037378 |
NPT2 | Others | Unspecified | IC50 | > | 80000 | nM | 19534474 | |
NPT3728 | Individual Protein | p53-binding protein Mdm-2 | Homo sapiens | EC50 | = | 7680 | nM | DrugMatrix in vitro pharmacology data |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 707.9 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 5171.4 | nM | DrugMatrix in vitro pharmacology data | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 56234.1 | nM | DrugMatrix in vitro pharmacology data | |
NPT2 | Others | Unspecified | Potency | 1584.9 | nM | DrugMatrix in vivo data: Hematology | ||
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 3162.3 | nM | 26090896 | |
NPT2 | Others | Unspecified | IC50 | > | 80000 | nM | 11881984 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC150978 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC123177 |
1.0 | High Similarity | NPC70595 |
1.0 | High Similarity | NPC74103 |
0.9882 | High Similarity | NPC253144 |
0.9767 | High Similarity | NPC284185 |
0.9444 | High Similarity | NPC169205 |
0.9438 | High Similarity | NPC48803 |
0.9438 | High Similarity | NPC90121 |
0.9438 | High Similarity | NPC275960 |
0.9438 | High Similarity | NPC193645 |
0.9412 | High Similarity | NPC70422 |
0.9412 | High Similarity | NPC104961 |
0.9412 | High Similarity | NPC70555 |
0.9341 | High Similarity | NPC54843 |
0.9341 | High Similarity | NPC141191 |
0.9333 | High Similarity | NPC185553 |
0.9294 | High Similarity | NPC21471 |
0.9294 | High Similarity | NPC33570 |
0.9294 | High Similarity | NPC161957 |
0.9059 | High Similarity | NPC39588 |
0.8966 | High Similarity | NPC238593 |
0.8901 | High Similarity | NPC167219 |
0.8876 | High Similarity | NPC52198 |
0.8876 | High Similarity | NPC117405 |
0.8854 | High Similarity | NPC203659 |
0.8842 | High Similarity | NPC225353 |
0.8837 | High Similarity | NPC215294 |
0.875 | High Similarity | NPC107787 |
0.875 | High Similarity | NPC110989 |
0.8736 | High Similarity | NPC115786 |
0.8706 | High Similarity | NPC223904 |
0.8696 | High Similarity | NPC289004 |
0.8681 | High Similarity | NPC111114 |
0.8681 | High Similarity | NPC261607 |
0.8681 | High Similarity | NPC300312 |
0.8636 | High Similarity | NPC78089 |
0.8621 | High Similarity | NPC54468 |
0.8488 | Intermediate Similarity | NPC69271 |
0.8488 | Intermediate Similarity | NPC74673 |
0.8478 | Intermediate Similarity | NPC286341 |
0.8478 | Intermediate Similarity | NPC191339 |
0.8462 | Intermediate Similarity | NPC12872 |
0.8462 | Intermediate Similarity | NPC168679 |
0.8391 | Intermediate Similarity | NPC35089 |
0.8391 | Intermediate Similarity | NPC281949 |
0.8391 | Intermediate Similarity | NPC39411 |
0.8391 | Intermediate Similarity | NPC10276 |
0.8391 | Intermediate Similarity | NPC255580 |
0.8391 | Intermediate Similarity | NPC25684 |
0.8391 | Intermediate Similarity | NPC301477 |
0.837 | Intermediate Similarity | NPC62815 |
0.8351 | Intermediate Similarity | NPC171759 |
0.8276 | Intermediate Similarity | NPC302426 |
0.8276 | Intermediate Similarity | NPC293418 |
0.8276 | Intermediate Similarity | NPC290508 |
0.8276 | Intermediate Similarity | NPC73052 |
0.8276 | Intermediate Similarity | NPC6823 |
0.8276 | Intermediate Similarity | NPC276356 |
0.8265 | Intermediate Similarity | NPC474747 |
0.8229 | Intermediate Similarity | NPC213947 |
0.8229 | Intermediate Similarity | NPC108475 |
0.8229 | Intermediate Similarity | NPC170143 |
0.8211 | Intermediate Similarity | NPC304886 |
0.8191 | Intermediate Similarity | NPC135776 |
0.8182 | Intermediate Similarity | NPC475945 |
0.8182 | Intermediate Similarity | NPC475871 |
0.8172 | Intermediate Similarity | NPC129419 |
0.8163 | Intermediate Similarity | NPC474742 |
0.8163 | Intermediate Similarity | NPC477950 |
0.8152 | Intermediate Similarity | NPC475906 |
0.8152 | Intermediate Similarity | NPC469628 |
0.8152 | Intermediate Similarity | NPC469631 |
0.8152 | Intermediate Similarity | NPC469653 |
0.8152 | Intermediate Similarity | NPC471047 |
0.814 | Intermediate Similarity | NPC476794 |
0.814 | Intermediate Similarity | NPC470240 |
0.8125 | Intermediate Similarity | NPC142529 |
0.8125 | Intermediate Similarity | NPC91771 |
0.8105 | Intermediate Similarity | NPC140543 |
0.8105 | Intermediate Similarity | NPC477131 |
0.8105 | Intermediate Similarity | NPC476267 |
0.81 | Intermediate Similarity | NPC474741 |
0.809 | Intermediate Similarity | NPC173609 |
0.8085 | Intermediate Similarity | NPC133698 |
0.8065 | Intermediate Similarity | NPC268298 |
0.8043 | Intermediate Similarity | NPC478144 |
0.8043 | Intermediate Similarity | NPC201658 |
0.8021 | Intermediate Similarity | NPC474490 |
0.8 | Intermediate Similarity | NPC473234 |
0.8 | Intermediate Similarity | NPC60386 |
0.8 | Intermediate Similarity | NPC318468 |
0.8 | Intermediate Similarity | NPC473263 |
0.8 | Intermediate Similarity | NPC473273 |
0.8 | Intermediate Similarity | NPC475873 |
0.8 | Intermediate Similarity | NPC153590 |
0.8 | Intermediate Similarity | NPC475947 |
0.8 | Intermediate Similarity | NPC308656 |
0.7978 | Intermediate Similarity | NPC471325 |
0.7978 | Intermediate Similarity | NPC141810 |
0.7957 | Intermediate Similarity | NPC475902 |
0.7955 | Intermediate Similarity | NPC63649 |
0.7955 | Intermediate Similarity | NPC270126 |
0.7955 | Intermediate Similarity | NPC469620 |
0.7955 | Intermediate Similarity | NPC182550 |
0.7955 | Intermediate Similarity | NPC617 |
0.7955 | Intermediate Similarity | NPC469690 |
0.7955 | Intermediate Similarity | NPC264227 |
0.7955 | Intermediate Similarity | NPC178277 |
0.7955 | Intermediate Similarity | NPC472965 |
0.7938 | Intermediate Similarity | NPC126156 |
0.7935 | Intermediate Similarity | NPC284902 |
0.7935 | Intermediate Similarity | NPC309757 |
0.7935 | Intermediate Similarity | NPC304558 |
0.7935 | Intermediate Similarity | NPC236692 |
0.7935 | Intermediate Similarity | NPC64153 |
0.7931 | Intermediate Similarity | NPC195785 |
0.7931 | Intermediate Similarity | NPC65603 |
0.7931 | Intermediate Similarity | NPC208223 |
0.7931 | Intermediate Similarity | NPC15975 |
0.7921 | Intermediate Similarity | NPC309190 |
0.7921 | Intermediate Similarity | NPC100487 |
0.7917 | Intermediate Similarity | NPC198853 |
0.7917 | Intermediate Similarity | NPC148463 |
0.7912 | Intermediate Similarity | NPC165287 |
0.7907 | Intermediate Similarity | NPC138408 |
0.7907 | Intermediate Similarity | NPC226669 |
0.7907 | Intermediate Similarity | NPC193351 |
0.7895 | Intermediate Similarity | NPC20713 |
0.7895 | Intermediate Similarity | NPC221282 |
0.7895 | Intermediate Similarity | NPC131209 |
0.7872 | Intermediate Similarity | NPC166919 |
0.7872 | Intermediate Similarity | NPC32922 |
0.7872 | Intermediate Similarity | NPC4986 |
0.7849 | Intermediate Similarity | NPC24728 |
0.7849 | Intermediate Similarity | NPC72513 |
0.7849 | Intermediate Similarity | NPC475703 |
0.7849 | Intermediate Similarity | NPC237540 |
0.7849 | Intermediate Similarity | NPC478145 |
0.7843 | Intermediate Similarity | NPC291643 |
0.7841 | Intermediate Similarity | NPC472960 |
0.7841 | Intermediate Similarity | NPC128276 |
0.783 | Intermediate Similarity | NPC209058 |
0.7826 | Intermediate Similarity | NPC125290 |
0.7826 | Intermediate Similarity | NPC165162 |
0.7826 | Intermediate Similarity | NPC110405 |
0.7826 | Intermediate Similarity | NPC155873 |
0.7816 | Intermediate Similarity | NPC123360 |
0.7812 | Intermediate Similarity | NPC475302 |
0.7812 | Intermediate Similarity | NPC200237 |
0.7802 | Intermediate Similarity | NPC272814 |
0.7802 | Intermediate Similarity | NPC474703 |
0.78 | Intermediate Similarity | NPC128733 |
0.78 | Intermediate Similarity | NPC185141 |
0.78 | Intermediate Similarity | NPC110443 |
0.78 | Intermediate Similarity | NPC46998 |
0.78 | Intermediate Similarity | NPC472753 |
0.78 | Intermediate Similarity | NPC47880 |
0.78 | Intermediate Similarity | NPC133907 |
0.7791 | Intermediate Similarity | NPC476355 |
0.7789 | Intermediate Similarity | NPC152467 |
0.7789 | Intermediate Similarity | NPC71533 |
0.7789 | Intermediate Similarity | NPC469368 |
0.7789 | Intermediate Similarity | NPC106510 |
0.7789 | Intermediate Similarity | NPC312042 |
0.7778 | Intermediate Similarity | NPC47635 |
0.7778 | Intermediate Similarity | NPC208233 |
0.7778 | Intermediate Similarity | NPC42470 |
0.7766 | Intermediate Similarity | NPC226863 |
0.7766 | Intermediate Similarity | NPC215831 |
0.7766 | Intermediate Similarity | NPC471149 |
0.7766 | Intermediate Similarity | NPC476805 |
0.7755 | Intermediate Similarity | NPC18019 |
0.7755 | Intermediate Similarity | NPC24956 |
0.7755 | Intermediate Similarity | NPC476275 |
0.7742 | Intermediate Similarity | NPC150755 |
0.7742 | Intermediate Similarity | NPC475461 |
0.7742 | Intermediate Similarity | NPC38576 |
0.7742 | Intermediate Similarity | NPC305475 |
0.7742 | Intermediate Similarity | NPC279859 |
0.7732 | Intermediate Similarity | NPC473316 |
0.7732 | Intermediate Similarity | NPC323008 |
0.7732 | Intermediate Similarity | NPC470010 |
0.7732 | Intermediate Similarity | NPC477130 |
0.7732 | Intermediate Similarity | NPC262133 |
0.7732 | Intermediate Similarity | NPC473330 |
0.7732 | Intermediate Similarity | NPC469632 |
0.7732 | Intermediate Similarity | NPC473331 |
0.7732 | Intermediate Similarity | NPC470013 |
0.7732 | Intermediate Similarity | NPC477129 |
0.7732 | Intermediate Similarity | NPC470697 |
0.7727 | Intermediate Similarity | NPC141789 |
0.7727 | Intermediate Similarity | NPC57744 |
0.7727 | Intermediate Similarity | NPC122264 |
0.7727 | Intermediate Similarity | NPC97516 |
0.7727 | Intermediate Similarity | NPC474760 |
0.7727 | Intermediate Similarity | NPC476028 |
0.7727 | Intermediate Similarity | NPC171204 |
0.7723 | Intermediate Similarity | NPC149371 |
0.7723 | Intermediate Similarity | NPC472754 |
0.7717 | Intermediate Similarity | NPC38569 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC150978 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9438 | High Similarity | NPD1698 | Clinical (unspecified phase) |
0.7872 | Intermediate Similarity | NPD1695 | Approved |
0.7692 | Intermediate Similarity | NPD5209 | Approved |
0.7634 | Intermediate Similarity | NPD1694 | Approved |
0.7604 | Intermediate Similarity | NPD5785 | Approved |
0.7596 | Intermediate Similarity | NPD7899 | Clinical (unspecified phase) |
0.7551 | Intermediate Similarity | NPD5282 | Discontinued |
0.7547 | Intermediate Similarity | NPD6371 | Approved |
0.7312 | Intermediate Similarity | NPD4752 | Clinical (unspecified phase) |
0.7263 | Intermediate Similarity | NPD1733 | Clinical (unspecified phase) |
0.7087 | Intermediate Similarity | NPD4225 | Approved |
0.7083 | Intermediate Similarity | NPD5363 | Approved |
0.701 | Intermediate Similarity | NPD5786 | Approved |
0.7 | Intermediate Similarity | NPD6411 | Approved |
0.6947 | Remote Similarity | NPD6435 | Approved |
0.6852 | Remote Similarity | NPD6008 | Approved |
0.6842 | Remote Similarity | NPD5369 | Approved |
0.68 | Remote Similarity | NPD6101 | Approved |
0.68 | Remote Similarity | NPD5764 | Clinical (unspecified phase) |
0.6771 | Remote Similarity | NPD4269 | Approved |
0.6771 | Remote Similarity | NPD4270 | Approved |
0.6765 | Remote Similarity | NPD5779 | Approved |
0.6765 | Remote Similarity | NPD5778 | Approved |
0.6737 | Remote Similarity | NPD5368 | Approved |
0.6701 | Remote Similarity | NPD7154 | Phase 3 |
0.6701 | Remote Similarity | NPD5362 | Discontinued |
0.67 | Remote Similarity | NPD6903 | Approved |
0.6696 | Remote Similarity | NPD7115 | Discovery |
0.6667 | Remote Similarity | NPD7146 | Approved |
0.6667 | Remote Similarity | NPD6684 | Approved |
0.6667 | Remote Similarity | NPD7521 | Approved |
0.6667 | Remote Similarity | NPD5330 | Approved |
0.6667 | Remote Similarity | NPD7983 | Approved |
0.6667 | Remote Similarity | NPD7334 | Approved |
0.6667 | Remote Similarity | NPD6409 | Approved |
0.6636 | Remote Similarity | NPD5697 | Approved |
0.6602 | Remote Similarity | NPD6399 | Phase 3 |
0.66 | Remote Similarity | NPD3573 | Approved |
0.6577 | Remote Similarity | NPD6899 | Approved |
0.6577 | Remote Similarity | NPD6881 | Approved |
0.6569 | Remote Similarity | NPD6698 | Approved |
0.6569 | Remote Similarity | NPD5207 | Approved |
0.6569 | Remote Similarity | NPD46 | Approved |
0.6562 | Remote Similarity | NPD4252 | Approved |
0.6559 | Remote Similarity | NPD8039 | Approved |
0.6549 | Remote Similarity | NPD6650 | Approved |
0.6549 | Remote Similarity | NPD6649 | Approved |
0.6538 | Remote Similarity | NPD7901 | Clinical (unspecified phase) |
0.6538 | Remote Similarity | NPD7900 | Approved |
0.6535 | Remote Similarity | NPD5737 | Approved |
0.6535 | Remote Similarity | NPD7513 | Clinical (unspecified phase) |
0.6535 | Remote Similarity | NPD6672 | Approved |
0.6526 | Remote Similarity | NPD5784 | Clinical (unspecified phase) |
0.6518 | Remote Similarity | NPD6014 | Approved |
0.6518 | Remote Similarity | NPD6013 | Approved |
0.6518 | Remote Similarity | NPD6012 | Approved |
0.6505 | Remote Similarity | NPD5693 | Phase 1 |
0.6491 | Remote Similarity | NPD6053 | Discontinued |
0.6476 | Remote Similarity | NPD6356 | Clinical (unspecified phase) |
0.646 | Remote Similarity | NPD7290 | Approved |
0.646 | Remote Similarity | NPD7102 | Approved |
0.646 | Remote Similarity | NPD6883 | Approved |
0.6429 | Remote Similarity | NPD7320 | Approved |
0.6429 | Remote Similarity | NPD6011 | Approved |
0.6429 | Remote Similarity | NPD6686 | Approved |
0.6408 | Remote Similarity | NPD7838 | Discovery |
0.6404 | Remote Similarity | NPD8130 | Phase 1 |
0.6404 | Remote Similarity | NPD6847 | Approved |
0.6404 | Remote Similarity | NPD6869 | Approved |
0.6404 | Remote Similarity | NPD6617 | Approved |
0.64 | Remote Similarity | NPD6082 | Clinical (unspecified phase) |
0.6396 | Remote Similarity | NPD6402 | Approved |
0.6396 | Remote Similarity | NPD5739 | Approved |
0.6396 | Remote Similarity | NPD6675 | Approved |
0.6396 | Remote Similarity | NPD7128 | Approved |
0.6392 | Remote Similarity | NPD5790 | Clinical (unspecified phase) |
0.6372 | Remote Similarity | NPD6373 | Approved |
0.6372 | Remote Similarity | NPD6372 | Approved |
0.6355 | Remote Similarity | NPD7902 | Approved |
0.6348 | Remote Similarity | NPD8297 | Approved |
0.6348 | Remote Similarity | NPD6882 | Approved |
0.6339 | Remote Similarity | NPD5701 | Approved |
0.6337 | Remote Similarity | NPD4249 | Approved |
0.6321 | Remote Similarity | NPD5695 | Phase 3 |
0.6311 | Remote Similarity | NPD7492 | Approved |
0.6296 | Remote Similarity | NPD5696 | Approved |
0.6292 | Remote Similarity | NPD2685 | Clinical (unspecified phase) |
0.6275 | Remote Similarity | NPD4250 | Approved |
0.6275 | Remote Similarity | NPD4251 | Approved |
0.6273 | Remote Similarity | NPD5211 | Phase 2 |
0.6262 | Remote Similarity | NPD7839 | Suspended |
0.626 | Remote Similarity | NPD6616 | Approved |
0.625 | Remote Similarity | NPD6054 | Approved |
0.625 | Remote Similarity | NPD6319 | Approved |
0.6239 | Remote Similarity | NPD4696 | Approved |
0.6239 | Remote Similarity | NPD5285 | Approved |
0.6239 | Remote Similarity | NPD5286 | Approved |
0.6226 | Remote Similarity | NPD7748 | Approved |
0.6226 | Remote Similarity | NPD6001 | Approved |
0.6224 | Remote Similarity | NPD4822 | Approved |
0.6224 | Remote Similarity | NPD4820 | Approved |
0.6224 | Remote Similarity | NPD4821 | Approved |
0.6224 | Remote Similarity | NPD4819 | Approved |
0.621 | Remote Similarity | NPD7078 | Approved |
0.6204 | Remote Similarity | NPD6083 | Phase 2 |
0.6204 | Remote Similarity | NPD6084 | Phase 2 |
0.6198 | Remote Similarity | NPD6291 | Clinical (unspecified phase) |
0.6198 | Remote Similarity | NPD6016 | Approved |
0.6198 | Remote Similarity | NPD6015 | Approved |
0.619 | Remote Similarity | NPD7637 | Suspended |
0.619 | Remote Similarity | NPD5284 | Approved |
0.619 | Remote Similarity | NPD5694 | Approved |
0.619 | Remote Similarity | NPD5281 | Approved |
0.619 | Remote Similarity | NPD6079 | Approved |
0.6186 | Remote Similarity | NPD4268 | Approved |
0.6186 | Remote Similarity | NPD4271 | Approved |
0.6161 | Remote Similarity | NPD5141 | Approved |
0.616 | Remote Similarity | NPD7736 | Approved |
0.6154 | Remote Similarity | NPD6904 | Approved |
0.6154 | Remote Similarity | NPD6673 | Approved |
0.6154 | Remote Similarity | NPD6080 | Approved |
0.6148 | Remote Similarity | NPD5988 | Approved |
0.6148 | Remote Similarity | NPD6370 | Approved |
0.6147 | Remote Similarity | NPD7638 | Approved |
0.614 | Remote Similarity | NPD5345 | Clinical (unspecified phase) |
0.6126 | Remote Similarity | NPD5224 | Approved |
0.6126 | Remote Similarity | NPD4633 | Approved |
0.6126 | Remote Similarity | NPD5226 | Approved |
0.6126 | Remote Similarity | NPD5225 | Approved |
0.6111 | Remote Similarity | NPD5220 | Clinical (unspecified phase) |
0.6111 | Remote Similarity | NPD5222 | Approved |
0.6111 | Remote Similarity | NPD5221 | Approved |
0.61 | Remote Similarity | NPD4800 | Clinical (unspecified phase) |
0.6095 | Remote Similarity | NPD5692 | Phase 3 |
0.6091 | Remote Similarity | NPD7639 | Approved |
0.6091 | Remote Similarity | NPD7640 | Approved |
0.6087 | Remote Similarity | NPD229 | Approved |
0.6071 | Remote Similarity | NPD5175 | Approved |
0.6071 | Remote Similarity | NPD5174 | Approved |
0.6066 | Remote Similarity | NPD8513 | Phase 3 |
0.6066 | Remote Similarity | NPD8517 | Approved |
0.6066 | Remote Similarity | NPD8515 | Approved |
0.6066 | Remote Similarity | NPD8516 | Approved |
0.6061 | Remote Similarity | NPD4695 | Discontinued |
0.6058 | Remote Similarity | NPD5208 | Approved |
0.6055 | Remote Similarity | NPD5173 | Approved |
0.6055 | Remote Similarity | NPD4755 | Approved |
0.6053 | Remote Similarity | NPD5954 | Clinical (unspecified phase) |
0.605 | Remote Similarity | NPD6274 | Approved |
0.604 | Remote Similarity | NPD5332 | Approved |
0.604 | Remote Similarity | NPD5331 | Approved |
0.6038 | Remote Similarity | NPD6050 | Approved |
0.6038 | Remote Similarity | NPD7515 | Phase 2 |
0.6036 | Remote Similarity | NPD5223 | Approved |
0.6034 | Remote Similarity | NPD4634 | Approved |
0.6033 | Remote Similarity | NPD7100 | Approved |
0.6033 | Remote Similarity | NPD7101 | Approved |
0.6019 | Remote Similarity | NPD3574 | Clinical (unspecified phase) |
0.6019 | Remote Similarity | NPD4629 | Approved |
0.6019 | Remote Similarity | NPD3618 | Phase 1 |
0.6019 | Remote Similarity | NPD5210 | Approved |
0.6017 | Remote Similarity | NPD4632 | Approved |
0.6016 | Remote Similarity | NPD7260 | Phase 2 |
0.6 | Remote Similarity | NPD5328 | Approved |
0.6 | Remote Similarity | NPD5370 | Suspended |
0.6 | Remote Similarity | NPD8029 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD4790 | Discontinued |
0.6 | Remote Similarity | NPD6317 | Approved |
0.5984 | Remote Similarity | NPD6059 | Approved |
0.5984 | Remote Similarity | NPD7319 | Approved |
0.5983 | Remote Similarity | NPD6401 | Clinical (unspecified phase) |
0.5983 | Remote Similarity | NPD8413 | Clinical (unspecified phase) |
0.598 | Remote Similarity | NPD3668 | Phase 3 |
0.598 | Remote Similarity | NPD3665 | Phase 1 |
0.598 | Remote Similarity | NPD3133 | Approved |
0.598 | Remote Similarity | NPD6400 | Clinical (unspecified phase) |
0.598 | Remote Similarity | NPD3666 | Approved |
0.5963 | Remote Similarity | NPD4697 | Phase 3 |
0.5952 | Remote Similarity | NPD8293 | Discontinued |
0.595 | Remote Similarity | NPD6313 | Approved |
0.595 | Remote Similarity | NPD6314 | Approved |
0.595 | Remote Similarity | NPD6335 | Approved |
0.5946 | Remote Similarity | NPD6648 | Approved |
0.5946 | Remote Similarity | NPD4700 | Approved |
0.5941 | Remote Similarity | NPD3667 | Approved |
0.5929 | Remote Similarity | NPD6052 | Approved |
0.5917 | Remote Similarity | NPD6868 | Approved |
0.5897 | Remote Similarity | NPD5955 | Clinical (unspecified phase) |
0.5893 | Remote Similarity | NPD5344 | Discontinued |
0.5888 | Remote Similarity | NPD4810 | Clinical (unspecified phase) |
0.5873 | Remote Similarity | NPD7507 | Approved |
0.587 | Remote Similarity | NPD7331 | Phase 2 |
0.5868 | Remote Similarity | NPD6009 | Approved |
0.5865 | Remote Similarity | NPD6098 | Approved |
0.5865 | Remote Similarity | NPD4519 | Discontinued |
0.5865 | Remote Similarity | NPD5279 | Phase 3 |
0.5865 | Remote Similarity | NPD4623 | Approved |
0.5865 | Remote Similarity | NPD6422 | Discontinued |
0.5862 | Remote Similarity | NPD4730 | Approved |
0.5862 | Remote Similarity | NPD4729 | Approved |
PubChem CID   | 442142 |
ChEMBL   | CHEMBL486196 |
ZINC   |
Molecular Weight:   | 304.13 |
ALogP:   | 0.5603 |
MLogP:   | 2.78 |
XLogP:   | 1.291 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 69.67 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 22 |